BR0014820A - Solução de diálise incluindo agente osmótico de poliglicol, e seu uso - Google Patents

Solução de diálise incluindo agente osmótico de poliglicol, e seu uso

Info

Publication number: BR0014820A
Authority: BR; Brazil
Prior art keywords: dialysis; subject; osmotic; dialysis solution; osmotic agent
Prior art date: 1999-10-15

Application number

BR0014820-2A

Other languages

English (en)

Portuguese (pt)

Inventor

Jaime Simon

Alan D Strickland

Robert M Strom

Original Assignee

Dow Chemical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-15

Filing date

2000-10-13

Publication date

2002-06-11

2000-10-13 Application filed by Dow Chemical Co filed Critical Dow Chemical Co

2002-06-11 Publication of BR0014820A publication Critical patent/BR0014820A/pt

Links

239000002357 osmotic agent Substances 0.000 title abstract 4
239000000385 dialysis solution Substances 0.000 title abstract 3
229920000151 polyglycol Polymers 0.000 title abstract 2
239000010695 polyglycol Substances 0.000 title abstract 2
238000000502 dialysis Methods 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
229940123457 Free radical scavenger Drugs 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
239000007857 degradation product Substances 0.000 abstract 1
230000001627 detrimental effect Effects 0.000 abstract 1
230000003204 osmotic effect Effects 0.000 abstract 1
210000003200 peritoneal cavity Anatomy 0.000 abstract 1
239000002516 radical scavenger Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1
230000001954 sterilising effect Effects 0.000 abstract 1
238000004659 sterilization and disinfection Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Urology & Nephrology (AREA)
External Artificial Organs (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BR0014820-2A 1999-10-15 2000-10-13 Solução de diálise incluindo agente osmótico de poliglicol, e seu uso BR0014820A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15981099P	1999-10-15	1999-10-15
PCT/US2000/028523 WO2001028544A2 (en)	1999-10-15	2000-10-13	Dialysis solution including polyglycol osmotic agent

Publications (1)

Publication Number	Publication Date
BR0014820A true BR0014820A (pt)	2002-06-11

Family

ID=22574137

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR0014820-2A BR0014820A (pt)	1999-10-15	2000-10-13	Solução de diálise incluindo agente osmótico de poliglicol, e seu uso

Country Status (8)

Country	Link
EP (1)	EP1223985B1 (de)
JP (1)	JP2003512322A (de)
AT (1)	ATE311203T1 (de)
AU (1)	AU7879500A (de)
BR (1)	BR0014820A (de)
CA (1)	CA2382864A1 (de)
DE (1)	DE60024479T2 (de)
WO (1)	WO2001028544A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7053059B2 (en)	2003-07-25	2006-05-30	Baxter International Inc.	Dialysis solutions with reduced levels of glucose degradation products
GB2421908A (en) *	2004-12-23	2006-07-12	Univ College London Hospitals	Medicament for treatment of inflammatory diseases
WO2006130599A2 (en)	2005-05-31	2006-12-07	Warsaw Orthopedic, Inc.	Compositions and methods for treating a damaged cardiovascular element
US8945623B2 (en) *	2006-05-03	2015-02-03	Warsaw Orthopedic, Inc.	Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US8840933B2 (en)	2006-05-03	2014-09-23	Warsaw Orthopedic, Inc.	Method of treating neuronal injury by administering magnesium chloride and PEG
ES2355853T3 (es) *	2006-06-22	2011-03-31	Gambro Lundia Ab	Solución que comprende n-acetilcisteína y ácido glucónico y métodos para reducir, tratar y/o prevenir el estrés oxidativo y la activación celular.
US8057458B2 (en)	2006-10-30	2011-11-15	Warsaw Orthopedic, Inc.	Method for treating facet pain
US9675696B2 (en)	2006-11-14	2017-06-13	Warsaw Orthopedic, Inc.	Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en)	2007-08-03	2012-04-10	Warsaw Orthopedic, Inc.	Compositions and methods for treating cavity conditions
ES2332636B1 (es) *	2008-08-06	2011-02-10	Universitat De Les Illes Balears	Composicion de liquido de dialisis.
US8858924B2 (en)	2009-03-26	2014-10-14	Warsaw Orthopedic, Inc.	Compositions and methods for treatment of hemorrhage
US8852566B2 (en)	2009-03-26	2014-10-07	Warsaw Orthopedic, Inc.	Compositions and methods for preferential distribution of active agents to injury sites
EP2411056A1 (de)	2009-03-26	2012-02-01	Warsaw Orthopedic, Inc.	Verfahren zur identifizierung von potenziellen komponenten für target-zusammensetzungen zur arzneimittelabgabe
US9244060B2 (en)	2009-03-26	2016-01-26	Warsaw Orthopedic, Inc.	Site localization and methods for monitoring treatment of disturbed blood vessels
US9078808B2 (en)	2009-03-26	2015-07-14	Warsaw Orthopedic, Inc.	Device to deliver magnesium in PEG formulation
CA2871277A1 (en) *	2012-04-24	2013-10-31	The University Of British Columbia	Polymer-based dialysate
WO2015074139A1 (en)	2013-11-21	2015-05-28	University Of British Columbia	Polymer based transplant preservation solution
JP6523614B2 (ja) *	2014-04-22	2019-06-05	日機装株式会社	使用済み透析液用の除水器及びそれを用いた透析液再生システム
EP3120842A1 (de)	2015-07-20	2017-01-25	Opterion Health AG	Peritoneale therapeutische flüssigkeit
US20250025615A1 (en) *	2021-12-01	2025-01-23	Gambro Lundia Ab	New dialysis fluid
CN115624566B (zh) *	2022-12-22	2023-03-10	广东省人民医院	一种腹膜透析液及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5496545A (en) *	1993-08-11	1996-03-05	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
EP0934352B1 (de) *	1996-10-23	2007-05-02	Dow Global Technologies Inc.	Wasserlösliche polymere für die verminderung der absorption von diätetikem phosphat oder oxalat

2000
- 2000-10-13 AT AT00968956T patent/ATE311203T1/de not_active IP Right Cessation
- 2000-10-13 EP EP00968956A patent/EP1223985B1/de not_active Expired - Lifetime
- 2000-10-13 CA CA002382864A patent/CA2382864A1/en not_active Abandoned
- 2000-10-13 JP JP2001531374A patent/JP2003512322A/ja active Pending
- 2000-10-13 AU AU78795/00A patent/AU7879500A/en not_active Abandoned
- 2000-10-13 BR BR0014820-2A patent/BR0014820A/pt not_active Application Discontinuation
- 2000-10-13 DE DE60024479T patent/DE60024479T2/de not_active Expired - Fee Related
- 2000-10-13 WO PCT/US2000/028523 patent/WO2001028544A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2001028544A2 (en)	2001-04-26
EP1223985A2 (de)	2002-07-24
EP1223985B1 (de)	2005-11-30
CA2382864A1 (en)	2001-04-26
JP2003512322A (ja)	2003-04-02
ATE311203T1 (de)	2005-12-15
WO2001028544A3 (en)	2001-11-29
DE60024479D1 (de)	2006-01-05
AU7879500A (en)	2001-04-30
DE60024479T2 (de)	2006-05-18

Legal Events

Date	Code	Title	Description
2005-09-06	B25A	Requested transfer of rights approved	Free format text: DOW GLOBAL TECHNOLOGIES INC. (US)
2009-08-25	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2010-03-09	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 10(VIII), 11, 13 E 25 DA LPI
2010-08-03	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

Publication	Publication Date	Title
BR0014820A (pt)	2002-06-11	Solução de diálise incluindo agente osmótico de poliglicol, e seu uso
US7053059B2 (en)	2006-05-30	Dialysis solutions with reduced levels of glucose degradation products
DE69101547D1 (de)	1994-05-05	Herzschrittmacher mit im Kreislauf platzierten Blutdruckaufnehmer zur Anzeige der Körperlage eines Patienten.
NO980500L (no)	1998-02-05	Biokompatibel vandig opplösning for anvendelse i kontinuerlig ambulatorisk peritoneal dialyse
TW287109B (de)	1996-10-01
TW224428B (de)	1994-06-01
HU910979D0 (en)	1991-10-28	Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives
AR042795A1 (es)	2005-07-06	Fluidos de dialisis biocompatibles que contienen icodextrinas
FI935693A7 (fi)	1994-06-18	Bifenyylin johdannaiset, niiden valmistus ja käyttö korkean verenpaineen ja sydäntautien hoitoon
DE69201255D1 (de)	1995-03-09	Senkung des Cholesterolspiegels im Blut durch Celluloseether.
SE9600631D0 (sv)	1996-02-20	Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
IL143824A0 (en)	2002-04-21	New dialysis method
MX9603515A (es)	1997-03-29	Preparacion farmaceutica que contiene activadores de plasminogeno.
ES2125696T3 (es)	1999-03-01	Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.
BR9713653B1 (pt)	2013-05-21	composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico.
ES2183417T3 (es)	2003-03-16	Concentrado para solucion medica y su utilizacion.
SE0301577L (sv)	2004-11-29	Lösning med låg natriumhalt
WO2007016377A3 (en)	2007-07-19	Dialysis solution including water-soluble polyelectrolyte osmotic agent
CA2507561C (en)	2011-09-20	A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
CN219803779U (zh)	2023-10-10	一种无菌美容针
CN1047318C (zh)	1999-12-15	一种创面覆盖物的制备方法
CN213031595U (zh)	2021-04-23	一种不易压伤口唇的牙垫保护套
Wilder	1989	In Struggles to Contain the AIDS Crisis, Plastics Play a Saving Role
ATE84228T1 (de)	1993-01-15	Spritze.
ES2031930T3 (es)	1993-01-01	Un metodo para obtener una preparacion liofilizada que contiene aspoxicilina como ingrediente activo.